Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
Dania Akbar, Taeho Greg Rhee, Felicia Ceban, et al.
CNS Drugs (2023) Vol. 37, Iss. 10, pp. 867-881
Closed Access | Times Cited: 16

Showing 16 citing articles:

Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 35
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 13
Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder
Kristine C. Willett, LeDea R. Bond, Amanda M. Morrill, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 1, pp. e24-e29
Closed Access | Times Cited: 6
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled clinical trial protocol
Shampa Maji, Debadatta Mohapatra, Monalisa Jena, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e080500-e080500
Open Access | Times Cited: 2
Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD)
Berend Olivier, Berend Olivier
Advances in experimental medicine and biology (2024), pp. 49-66
Closed Access | Times Cited: 2
Newer Treatments for Mood and Anxiety Disorders
Jesse Markman, Heidi Combs
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 911-921
Closed Access | Times Cited: 1
The Association Between Dextromethorphan/Bupropion with Alcohol and Substance Misuse: Reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
Angela T.H. Kwan, Roger S. McIntyre
CNS Spectrums (2024), pp. 1-5
Open Access | Times Cited: 1
The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?
B.M. Petrescu, Ileana Marinescu, Dragoș Marinescu, et al.
Psihiatru ro (2023) Vol. 4, Iss. 75, pp. 5-5
Open Access | Times Cited: 2
Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder
Joseph Blanco, Pamela Quimbaya, M. Mena, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 9, pp. 837-848
Closed Access
Dextromethorphan: A Double-Edged Drug - Unveiling the Pernicious Repercussions of Abuse and Forensic Implications
L. K. Gupta, Neha Tomar, Rajendra Kumar Sarin
Emerging Trends in Drugs Addictions and Health (2024) Vol. 4, pp. 100161-100161
Open Access
Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms
Kyoung Ja Kwon, Hahn Young Kim, Seol‐Heui Han, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11338-11338
Open Access
Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial
Shampa Maji, Archana Mishra, Debadatta Mohapatra, et al.
Psychiatry Research (2024) Vol. 342, pp. 116257-116257
Closed Access
Emerging medications in psychiatry: Transforming the treatment landscape for depression and psychosis in Parkinson’s disease
Brijesh Saran, Tripta S. Bhagat, Rohit Bhagat
Santosh University Journal of Health Sciences (2024) Vol. 10, Iss. 2, pp. 209-219
Closed Access
Music Medicine for Neurological Disorders
Neelima B. Chauhan, Mahesh Kale, Purva Gujar-Kale, et al.
Integrated science (2024), pp. 811-850
Closed Access
Page 1

Scroll to top